Comments
Loading...
Inhibikase Therapeutics Rapporto sugli interessi allo scoperto
IKTNASDAQ
Report sulle vendite allo scoperto
Il short interest su Inhibikase Therapeutics Inc (NASDAQ:IKT) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 3.48M a 3.20M. Questo rappresenta il 10.59% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Inhibikase Therapeutics Corp (XNAS:IKT) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 88.46K azioni scambiate al giorno, ci vorrebbero 36.12 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
3.20M
Vendite allo scoperto %
10.6%
Giorni di copertura
36.12
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
IKT | Inhibikase Therapeutics, Inc. | 10/15/2025 | 10/24/2025 | 10.59% | 30,183,735 | 3,195,011 | 88,456 | 36.12 | |
IKT | Inhibikase Therapeutics, Inc. | 09/30/2025 | 10/09/2025 | 11.52% | 30,183,735 | 3,476,754 | 183,258 | 18.97 | |
IKT | Inhibikase Therapeutics, Inc. | 09/15/2025 | 09/24/2025 | 10.53% | 30,183,735 | 3,178,278 | 100,628 | 31.58 | |
IKT | Inhibikase Therapeutics, Inc. | 08/29/2025 | 09/10/2025 | 11.00% | 30,183,735 | 3,319,737 | 87,443 | 37.96 | |
IKT | Inhibikase Therapeutics, Inc. | 08/15/2025 | 08/26/2025 | 10.91% | 30,183,735 | 3,293,418 | 110,533 | 29.8 | |
IKT | Inhibikase Therapeutics, Inc. | 07/31/2025 | 08/11/2025 | 10.11% | 30,008,640 | 3,033,758 | 123,948 | 24.48 | |
IKT | Inhibikase Therapeutics, Inc. | 07/15/2025 | 07/24/2025 | 10.24% | 30,008,640 | 3,073,788 | 138,063 | 22.26 | |
IKT | Inhibikase Therapeutics, Inc. | 06/30/2025 | 07/10/2025 | 10.87% | 30,008,640 | 3,262,325 | 914,446 | 3.57 | |
IKT | Inhibikase Therapeutics, Inc. | 06/13/2025 | 06/25/2025 | 5.28% | 30,008,640 | 1,585,212 | 97,033 | 16.34 | |
IKT | Inhibikase Therapeutics, Inc. | 05/30/2025 | 06/10/2025 | 5.18% | 30,008,640 | 1,555,196 | 125,673 | 12.37 | |
IKT | Inhibikase Therapeutics, Inc. | 05/15/2025 | 05/27/2025 | 4.60% | 30,008,640 | 1,381,659 | 109,900 | 12.57 | |
IKT | Inhibikase Therapeutics, Inc. | 04/30/2025 | 05/09/2025 | 4.85% | 29,950,615 | 1,454,085 | 114,857 | 12.66 | |
IKT | Inhibikase Therapeutics, Inc. | 04/15/2025 | 04/25/2025 | 2.42% | 58,864,579 | 1,421,862 | 157,159 | 9.05 | |
IKT | Inhibikase Therapeutics, Inc. | 03/31/2025 | 04/09/2025 | 2.24% | 58,864,579 | 1,317,901 | 131,190 | 10.05 | |
IKT | Inhibikase Therapeutics, Inc. | 03/14/2025 | 03/25/2025 | 2.21% | 58,864,579 | 1,303,346 | 117,812 | 11.06 | |
IKT | Inhibikase Therapeutics, Inc. | 02/28/2025 | 03/11/2025 | 2.34% | 58,864,579 | 1,375,069 | 220,970 | 6.22 | |
IKT | Inhibikase Therapeutics, Inc. | 02/14/2025 | 02/26/2025 | 2.14% | 58,864,579 | 1,261,295 | 166,857 | 7.56 | |
IKT | Inhibikase Therapeutics, Inc. | 01/31/2025 | 02/11/2025 | 1.93% | 55,545,182 | 1,070,610 | 225,745 | 4.74 | |
IKT | Inhibikase Therapeutics, Inc. | 01/15/2025 | 01/27/2025 | 1.61% | 55,545,182 | 895,808 | 149,876 | 5.98 | |
IKT | Inhibikase Therapeutics, Inc. | 12/31/2024 | 01/10/2025 | 1.61% | 53,375,313 | 856,885 | 562,072 | 1.52 | |
IKT | Inhibikase Therapeutics, Inc. | 12/13/2024 | 12/24/2024 | 1.26% | 53,375,313 | 672,186 | 293,537 | 2.29 | |
IKT | Inhibikase Therapeutics, Inc. | 11/29/2024 | 12/10/2024 | 0.54% | 53,375,313 | 287,662 | 181,130 | 1.59 | |
IKT | Inhibikase Therapeutics, Inc. | 11/15/2024 | 11/26/2024 | 0.57% | 53,375,313 | 305,663 | 366,733 | 1 | |
IKT | Inhibikase Therapeutics, Inc. | 10/31/2024 | 11/11/2024 | 0.29% | 64,942,503 | 187,953 | 371,321 | 1 | |
IKT | Inhibikase Therapeutics, Inc. | 10/15/2024 | 10/24/2024 | 0.35% | 64,942,503 | 227,278 | 1,947,874 | 1 | |
IKT | Inhibikase Therapeutics, Inc. | 09/30/2024 | 10/09/2024 | 0.67% | 6,632,503 | 44,110 | 19,967 | 2.21 | |
IKT | Inhibikase Therapeutics, Inc. | 09/13/2024 | 09/24/2024 | 0.60% | 6,632,503 | 39,655 | 18,571 | 2.14 | |
IKT | Inhibikase Therapeutics, Inc. | 08/30/2024 | 09/11/2024 | 0.66% | 6,632,503 | 44,041 | 29,226 | 1.51 | |
IKT | Inhibikase Therapeutics, Inc. | 08/15/2024 | 08/26/2024 | 0.83% | 6,632,503 | 54,801 | 14,232 | 3.85 | |
IKT | Inhibikase Therapeutics, Inc. | 07/31/2024 | 08/09/2024 | 0.96% | 6,384,578 | 61,011 | 30,004 | 2.03 | |
IKT | Inhibikase Therapeutics, Inc. | 07/15/2024 | 07/24/2024 | 0.72% | 6,384,578 | 45,795 | 31,515 | 1.45 | |
IKT | Inhibikase Therapeutics, Inc. | 06/28/2024 | 07/10/2024 | 0.83% | 6,384,578 | 52,921 | 24,114 | 2.19 | |
IKT | Inhibikase Therapeutics, Inc. | 06/14/2024 | 06/26/2024 | 1.46% | 6,384,578 | 93,489 | 19,117 | 4.89 | |
IKT | Inhibikase Therapeutics, Inc. | 05/31/2024 | 06/11/2024 | 1.71% | 7,094,070 | 121,292 | 43,460 | 2.79 | |
IKT | Inhibikase Therapeutics, Inc. | 05/15/2024 | 05/24/2024 | 6.12% | 5,646,269 | 345,455 | 94,893 | 3.64 | |
IKT | Inhibikase Therapeutics, Inc. | 04/30/2024 | 05/09/2024 | 2.40% | 5,646,269 | 135,255 | 77,484 | 1.75 | |
IKT | Inhibikase Therapeutics, Inc. | 04/15/2024 | 04/24/2024 | 0.97% | 5,646,269 | 54,568 | 36,317 | 1.5 | |
IKT | Inhibikase Therapeutics, Inc. | 03/28/2024 | 04/09/2024 | 0.36% | 5,669,587 | 20,281 | 55,162 | 1 | |
IKT | Inhibikase Therapeutics, Inc. | 03/15/2024 | 03/26/2024 | 0.57% | 5,289,036 | 30,250 | 48,061 | 1 | |
IKT | Inhibikase Therapeutics, Inc. | 02/29/2024 | 03/11/2024 | 0.97% | 5,289,036 | 51,343 | 76,410 | 1 | |
IKT | Inhibikase Therapeutics, Inc. | 02/15/2024 | 02/27/2024 | 1.61% | 5,289,036 | 85,349 | 272,553 | 1 | |
IKT | Inhibikase Therapeutics, Inc. | 01/31/2024 | 02/09/2024 | 1.17% | 5,289,036 | 61,675 | 303,499 | 1 | |
IKT | Inhibikase Therapeutics, Inc. | 01/12/2024 | 01/24/2024 | 0.17% | 5,277,036 | 8,780 | 58,127 | 1 | |
IKT | Inhibikase Therapeutics, Inc. | 12/29/2023 | 01/10/2024 | 0.18% | 5,277,036 | 9,494 | 89,869 | 1 | |
IKT | Inhibikase Therapeutics, Inc. | 12/15/2023 | 12/27/2023 | 1.05% | 5,277,036 | 55,180 | 247,466 | 1 | |
IKT | Inhibikase Therapeutics, Inc. | 11/30/2023 | 12/11/2023 | 0.73% | 5,277,036 | 38,577 | 62,711 | 1 | |
IKT | Inhibikase Therapeutics, Inc. | 11/15/2023 | 11/27/2023 | 2.64% | 5,277,036 | 139,183 | 51,275 | 2.71 | |
IKT | Inhibikase Therapeutics, Inc. | 10/31/2023 | 11/09/2023 | 4.00% | 4,451,082 | 177,889 | 58,840 | 3.02 |
In cerca di azioni più vendute allo scoperto?